|
PDCL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.20609999998411E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.612800E-04 |
| Normal-vs-Stage2 |
1.504070E-02 |
| Normal-vs-Stage3 |
3.87960000014509E-07 |
| Normal-vs-Stage4 |
1.99389948996043E-10 |
| Stage1-vs-Stage2 |
9.152600E-01 |
| Stage1-vs-Stage3 |
1.422090E-02 |
| Stage1-vs-Stage4 |
3.58390000000375E-05 |
| Stage2-vs-Stage3 |
1.300410E-01 |
| Stage2-vs-Stage4 |
1.939270E-03 |
| Stage3-vs-Stage4 |
3.082400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.03550000042053E-07 |
| Normal-vs-AfricanAmerican |
1.529720E-02 |
| Normal-vs-Asian |
5.579100E-03 |
| Caucasian-vs-AfricanAmerican |
6.171400E-01 |
| Caucasian-vs-Asian |
4.114200E-01 |
| AfricanAmerican-vs-Asian |
9.211600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99450000000412E-05 |
| Normal-vs-Female |
2.08919999999946E-06 |
| Male-vs-Female |
9.217400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.422300E-03 |
| Normal-vs-Age(41-60Yrs) |
4.6665999997586E-07 |
| Normal-vs-Age(61-80Yrs) |
3.63379999979152E-07 |
| Normal-vs-Age(81-100Yrs) |
1.675810E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.295600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.441930E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.528200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.286400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.331400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.746000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.756100E-03 |
| Classical-VS-Follicular |
3.760200E-01 |
| Classical-VS-Other |
2.525600E-01 |
| Classical-VS-Normal |
9.014000E-04 |
| Tall-VS-Follicular |
4.418100E-02 |
| Tall-VS-Other |
8.334200E-01 |
| Tall-VS-Normal |
3.27259999988172E-07 |
| Follicular-VS-Other |
4.536200E-01 |
| Follicular-VS-Normal |
3.026700E-04 |
| Other-VS-Normal |
6.301600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22099999999115E-05 |
| Normal-vs-N1 |
1.9483799999942E-05 |
| N0-vs-N1 |
1.436200E-01 |
|
|
